Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct 19:2021:6806500.
doi: 10.1155/2021/6806500. eCollection 2021.

Myocarditis in the Setting of Recent COVID-19 Vaccination

Affiliations
Case Reports

Myocarditis in the Setting of Recent COVID-19 Vaccination

Laura Onderko et al. Case Rep Cardiol. .

Abstract

We report three patients who presented with chest pain after receiving either the BNT162b2 Pfizer/BioNTech or mRNA-1273 Moderna/NIH vaccine. Clinical presentation, biomarker, and cardiac MRI supported myocarditis. It is imperative that potential side effects of COVID-19 vaccine are reported to improve our knowledge about COVID-19 and mRNA vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Cardiac MRI of patient C: (a) T2 map demonstrating increased T2 signal consistent with edema in epicardium of the apical lateral wall; (b) four-chamber view showing late gadolinium enhancement in the apical lateral wall; (c) ECV map showing increased signal consistent with edema in the midanterolateral segments; (d) short axis with late gadolinium enhancements in the midanterolateral segments.
Figure 2
Figure 2
Patient D cardiac MRI: (a) T2 map demonstrating increased T2 signal consistent with edema in the epicardium of the apical lateral wall; (b–d) 3-chamber, 4-chamber, and apical short axis delayed images, respectively, demonstrating epicardial late gadolinium enhancement (LGE) corresponding to area of edema on T2 map.

References

    1. Polack F. P., Thomas S. J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine . 2020;383(27):2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Montgomery J., Ryan M., Engler R., et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology . 2021;6(10):p. 1202. doi: 10.1001/jamacardio.2021.2833. - DOI - PMC - PubMed
    1. Diaz G. A., Parsons G. T., Gering S. K., Meier A. R., Hutchinson I. V., Robicsek A. Myocarditis and pericarditis after vaccination for COVID-19. JAMA . 2021;326(12):p. 1210. doi: 10.1001/jama.2021.13443. - DOI - PMC - PubMed
    1. Tschope C., Ammirati E., Bozkurt B., et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology . 2021;18(3):169–193. doi: 10.1038/s41569-020-00435-x. - DOI - PMC - PubMed
    1. Levin D., Shimon G., Fadlon-Derai M., et al. Myocarditis following COVID-19 vaccination - a case series. Vaccine . 2021;39(42):6195–6200. doi: 10.1016/j.vaccine.2021.09.004. - DOI - PMC - PubMed

Publication types

LinkOut - more resources